Cas no 1523617-90-4 (tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate)
tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate
- AKOS025146815
- PB15310
- 3-azabicyclo[3.1.1]heptane-3-carboxylic acid, 6-hydroxy-, 1,1-dimethylethyl ester
- DB-189440
- (1R,5S,6R)-rel-3-Boc-6-hydroxy-3-azabicyclo[3.1.1]heptane
- DTXSID901159443
- 1,1-Dimethylethyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate
- FIPZGKLMWFRNLL-UHFFFAOYSA-N
- 3-azabicyclo[3.1.1]heptane-3-carboxylicacid,6-hydroxy-,1,1-dimethylethylester
- 1357353-36-6
- EN300-1168688
- 3-Boc-3-azabicyclo[3.1.1]heptane-6-ol
- 6-HYDROXY-3-AZABICYCLO[3.1.1]HEPTANE-3-CARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER
- 1523617-90-4
- MFCD22209399
- SY103464
- CS-0154766
- SCHEMBL17630406
- AS-42898
- 6-Hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylic acid, 1,1-dimethylethyl ester
- HEC35336
-
- MDL: MFCD17168421
- Inchi: 1S/C11H19NO3/c1-11(2,3)15-10(14)12-5-7-4-8(6-12)9(7)13/h7-9,13H,4-6H2,1-3H3
- InChI Key: FIPZGKLMWFRNLL-UHFFFAOYSA-N
- SMILES: OC1C2CN(C(=O)OC(C)(C)C)CC1C2
Computed Properties
- Exact Mass: 213.13649347g/mol
- Monoisotopic Mass: 213.13649347g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 15
- Rotatable Bond Count: 3
- Complexity: 260
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 2
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 49.8?2
tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X02715-100mg |
tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 95% | 100mg |
¥960.0 | 2024-07-18 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X02715-1g |
tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 95% | 1g |
¥5633.0 | 2024-07-18 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X02715-250mg |
tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 95% | 250mg |
¥1882.0 | 2024-07-18 | |
| Chemenu | CM325436-250mg |
tert-butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 95%+ | 250mg |
$396 | 2023-01-19 | |
| Chemenu | CM325436-1g |
tert-butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 95%+ | 1g |
$929 | 2023-01-19 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-XJ610-50mg |
tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 95% | 50mg |
691.0CNY | 2021-07-14 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-XJ610-200mg |
tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 95% | 200mg |
1725.0CNY | 2021-07-14 | |
| eNovation Chemicals LLC | Y1210753-100mg |
tert-butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 97% | 100mg |
$190 | 2024-07-21 | |
| eNovation Chemicals LLC | Y1210753-250MG |
tert-butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 97% | 250mg |
$350 | 2024-07-21 | |
| eNovation Chemicals LLC | Y1210753-500MG |
tert-butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate |
1523617-90-4 | 97% | 500mg |
$585 | 2024-07-21 |
tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate Related Literature
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
-
Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
-
Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
Additional information on tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate
Comprehensive Overview of tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate (CAS No. 1523617-90-4)
The compound tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate (CAS No. 1523617-90-4) is a highly specialized bicyclic organic molecule that has garnered significant attention in pharmaceutical and synthetic chemistry research. Its unique azabicyclo[3.1.1]heptane core structure, combined with the tert-butyl carboxylate and hydroxy functional groups, makes it a versatile intermediate for drug discovery and development. Researchers are particularly interested in its potential applications in central nervous system (CNS) therapeutics, owing to its structural similarity to bioactive alkaloids.
In recent years, the demand for tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate has surged due to its role in synthesizing novel small-molecule inhibitors and protease-targeting drugs. The compound’s bicyclic scaffold is a key feature for achieving high binding affinity in enzyme inhibition, a topic frequently searched in AI-driven drug design platforms. Its hydroxy group at the 6-position also allows for further derivatization, enabling the creation of libraries for high-throughput screening (HTS).
From an industrial perspective, the synthesis of CAS No. 1523617-90-4 involves multi-step organic reactions, including Boc protection and ring-closing strategies. These processes are often optimized for scalability, a hot topic in green chemistry forums. The compound’s stability under various pH conditions further enhances its utility in prodrug formulations, a trending subject in pharmacokinetics research.
Another area of interest is the compound’s potential in neurodegenerative disease research. Given the rising global focus on Alzheimer’s and Parkinson’s therapies, the 3-azabicyclo[3.1.1]heptane moiety is being explored for its ability to cross the blood-brain barrier (BBB). This aligns with frequent search queries like “BBB-permeable scaffolds” and “CNS drug delivery systems” in academic databases.
Quality control of tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate is critical, with analytical techniques such as HPLC, NMR, and mass spectrometry ensuring purity. These methods are commonly discussed in AI-powered literature reviews, reflecting the compound’s importance in precision medicine. Additionally, its chiral centers pose challenges in stereoselective synthesis, a niche yet growing field in asymmetric catalysis.
In summary, CAS No. 1523617-90-4 represents a cutting-edge building block in medicinal chemistry, bridging gaps between synthetic feasibility and therapeutic innovation. Its relevance to drug discovery, green synthesis, and CNS targeting ensures its continued prominence in both academic and industrial research.
1523617-90-4 (tert-Butyl 6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate) Related Products
- 1087784-78-8(Tert-butyl 1-(hydroxymethyl)-3-azabicyclo[3.1.1]heptane-3-carboxylate)
- 1407974-33-7(Tert-butyl 4-hydroxy-3-(2-hydroxyethyl)piperidine-1-carboxylate)
- 1357353-36-6(tert-butyl rel-(1R,5S,6r)-6-hydroxy-3-azabicyclo[3.1.1]heptane-3-carboxylate)
- 1367935-91-8(tert-Butyl 5-hydroxy-2,9-diazaspiro[5.5]undecane-9-carboxylate)
- 1782511-79-8(tert-butyl 5-hydroxy-2-azaspiro[5.5]undecane-2-carboxylate)
- 914654-74-3(tert-butyl 3-(2-hydroxypropan-2-yl)piperidine-1-carboxylate)
- 1368038-01-0(tert-butyl 5-hydroxy-2,9-diazaspiro[5.5]undecane-2-carboxylate)
- 389890-40-8(tert-butyl 9-hydroxy-3-azabicyclo[3.3.1]nonane-3-carboxylate)
- 377780-25-1(Tert-Butyl 3-(1-hydroxyethyl)piperidine-1-carboxylate)
- 2383771-86-4(Tert-butyl 9-hydroxy-6-azaspiro[3.5]nonane-6-carboxylate)